You Mo

shantou university

H指数:5

被引数:150

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Obesity increases the risk of radiation-induced interstitial lung disease in lung cancer patients: Evidence for a renin-mediated mechanism

肥胖增加肺癌患者辐射诱导的间质性肺疾病风险：肾素介导机制的依据

Therapeutic Advances in Medical Oncology

IF4.2

2026-10-100

PRE

Induction chemotherapy administration increases the risk of radiation pneumonitis in unresectable stage III NSCLC patients undergoing concurrent chemoradiotherapy with immunotherapy

诱导化疗给药会增加不可切除的III期NSCLC患者在同步放化疗联合免疫治疗过程中发生放射性肺炎的风险。

Therapeutic Advances in Medical Oncology

IF4.2

2026-02-200

PRE

A supramolecular peptide reprograms PD-L1+ tumor-associated macrophages to enhance antitumor immunity in lung adenocarcinoma

Journal of Controlled Release

IF11.5

2026-01-220

PRE

Early Immune Checkpoint Inhibitor Administration Increases the Risk of Radiation-Induced Pneumonitis in Patients with Stage III Unresectable NSCLC Undergoing Chemoradiotherapy

早期免疫检查点抑制剂给药会增加接受化疗放疗的III期不可切除非小细胞肺癌患者发生放射性肺炎的风险

CANCERS

IF4.4

2025-05-200

Concurrent immunotherapy improves progression-free survival but increases toxicity in unresectable stage III NSCLC

联合免疫疗法可改善不可切除的III期非小细胞肺癌的无进展生存期，但会增加其毒性。

LUNG CANCER

IF4.4

2025-05-010

PRE

Gut Escherichia coli promotes lung cancer by increasing circulating STAMBP production

肠道大肠杆菌通过增加循环STAMBP的产生来促进肺癌

DISCOVER ONCOLOGY

IF2.9

2025-04-030

Beta-adrenergic receptor blockers improve survival in patients with advanced non-small cell lung cancer combined with hypertension undergoing radiotherapy

SCIENTIFIC REPORTS

IF3.9

2025-03-280

OAAI

Risk of second primary cancer in young breast cancer survivors: an important yet overlooked issue

年轻乳腺癌幸存者发生第二原发癌症的风险：一个重要却被忽视的问题

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2025-02-240

Excessive lymph node dissection increases postoperative cardiovascular disease risk in non-small cell lung cancer patients

SCIENTIFIC REPORTS

IF3.9

2025-02-170

OAAI

The burden of COVID-19 death for different cancer types: a large population-based study

不同癌症类型的COVID-19死亡负担：一项大型基于人群的研究

JOURNAL OF GLOBAL HEALTH

IF4.3

2025-02-140

Sex-specific difference for melanoma from immunotherapy advancement

FRONTIERS IN ONCOLOGY

IF3.3

2024-11-140

OAAI

CD34 as a potential prognostic indicator for camrelizumab response in advanced non-small-cell lung cancer: insights from digital spatial profiling

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2024-10-170

OAAI

Sex-specific Difference for Small Cell Lung Cancer from Immunotherapy Advancement

从免疫治疗进展看小细胞肺癌的性别特异性差异

ARCHIVOS DE BRONCONEUMOLOGIA

IF9.2

2024-10-010

OAAI

The prognostic value of postoperative radiotherapy in right tumor for lung related death: based on SEER database and real-world data

FRONTIERS IN ONCOLOGY

IF3.3

2023-04-061

OAAI

Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based study

FRONTIERS IN ONCOLOGY

IF3.3

2022-10-062

OAAI

Epigallocatechin-3-gallate regulates mitofusin 2 expression through the peroxisome proliferator-activated receptor-γ coactivator-1α and estrogen-related receptor-α pathway

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

2018-11-012

PREAI

LncRNA PlncRNA-1 regulates proliferation and differentiation of hair follicle stem cells through TGF-1-mediated Wnt/-catenin signal pathway

LncRNA PlncRNA-1通过TGF-1-mediated Wnt/-catenin信号通路调控毛囊干细胞的增殖和分化

MOLECULAR MEDICINE REPORTS

IF3.5

2017-11-0358

OAAI

You Mo

个人简介

教育背景

工作经历

荣誉奖项

研究方向